Clear Search

Showing 1 result for “Lübker C Holst-Hansen T” published 2023.

May 2023

The Improved Health Utility of Once-Weekly Subcutaneous Semaglutide 2.4 mg Compared With Placebo in the STEP 1-4 Obesity Trials

Diabetes Obes Metab 2023 DOI 10.1111/dom.15090

Patient-reported outcomes and evaluations serve to shape policy through cost-effectiveness comparisons, assessing the incremental expenses of an intervention against the incremental enhancement in quality-adjusted life years.

more…